Sinenhlanhla X. H. Mthembu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sinenhlanhla X. H. Mthembu has a total of 63 co-authors. Here are the top co-authors by number of shared publications:
- Khanyisani Ziqubu
Department of Biochemistry, North-West University, Mmabatho 2745, South Africa
15 shared publications - Phiwayinkosi Vusi Dludla
Department of Biochemistry and Microbiology, University of Zululand, KwaDlangezwa 3886, South Africa
15 shared publications Bongani B. Nkambule
School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, 4000, South Africa
14 shared publications- Sithandiwe Eunice Mazibuko-Mbeje
Department of Biochemistry, North-West University, Mmabatho 2745, South Africa
14 shared publications Sithandiwe E. Mazibuko-Mbeje
Department of Biochemistry, North-West University, Mafikeng Campus, Mmabatho, 2735, South Africa
11 shared publicationsLuca Tiano
Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona, 60131, Italy
10 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1873 (1)
Oxidative lipoprotein remodelling in atherogenesis: Mechanistic insights and therapeutic potential
- 18 September 2026
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1873 (1)
Open AccessOxidative lipoprotein remodelling in atherogenesis: Mechanistic insights and therapeutic potential
- Open Access
- 7 August 2025
- Published by Elsevier in Atherosclerosis
- Vol. 409, 120474
Pharmacological activation of Nrf2: Cardioprotective effects of statins and metformin against dyslipidemia-induced oxidative stress
- 7 August 2025
- Published by Elsevier in Atherosclerosis
- Vol. 409, 120474
Open AccessPharmacological activation of Nrf2: Cardioprotective effects of statins and metformin against dyslipidemia-induced oxidative stress
- Open Access
- 13 March 2025
- Published by Elsevier in Toxicology in Vitro
- Vol. 106, 106052
Prolonged exposure to simvastatin affects coenzyme Q9/10 status leading to impaired mitochondrial respiratory capacity and reduced viability of cultured cardiac cells
- 13 March 2025
- Published by Elsevier in Toxicology in Vitro
- Vol. 106, 106052
Open AccessProlonged exposure to simvastatin affects coenzyme Q9/10 status leading to impaired mitochondrial respiratory capacity and reduced viability of cultured cardiac cells
- Open Access
- 5 January 2025
- Published by Elsevier in Metabolism Open
- Vol. 25, 100346
Supplementation with aspalathin and sulforaphane protects cultured cardiac cells against dyslipidemia-associated oxidative damage
- 5 January 2025
- Published by Elsevier in Metabolism Open
- Vol. 25, 100346
Open AccessSupplementation with aspalathin and sulforaphane protects cultured cardiac cells against dyslipidemia-associated oxidative damage
- Open Access
- 2 February 2024
- Published by Elsevier in Toxicology Reports
- Vol. 12, 234-243
Low levels and partial exposure to palmitic acid improves mitochondrial function and the oxidative status of cultured cardiomyoblasts
- 2 February 2024
- Published by Elsevier in Toxicology Reports
- Vol. 12, 234-243
Open AccessLow levels and partial exposure to palmitic acid improves mitochondrial function and the oxidative status of cultured cardiomyoblasts
- Open Access
- 4 December 2023
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 476 (3) , 283-293
Potential regulatory role of PGC-1α within the skeletal muscle during metabolic adaptations in response to high-fat diet feeding in animal models
High-fat diet (HFD) feeding in rodents has become an essential tool to critically analyze and study the pathological effects of obesity, including mitochondrial dysfunction and insulin resistance. Peroxisome proliferator–activated receptor γ coactivator-1α (PGC-1α) regulates cellular energy metabolism to influence insulin sensitivity, beyond its active role in stimulating mitochondrial biogenesis to facilitate skeletal muscle adaptations in response to HFD feeding. Here, some of the major electronic databases like PubMed, Embase, and Web of Science were accessed to update and critically discuss information on the potential role of PGC-1α during metabolic adaptations within the skeletal muscle in response to HFD feeding in rodents. In fact, available evidence suggests that partial exposure to HFD feeding (potentially during the early stages of disease development) is associated with impaired metabolic adaptations within the skeletal muscle, including mitochondrial dysfunction and reduced insulin sensitivity. In terms of implicated molecular mechanisms, these negative effects are partially associated with reduced activity of PGC-1α, together with the phosphorylation of protein kinase B and altered expression of genes involving nuclear respiratory factor 1 and mitochondrial transcription factor A within the skeletal muscle. Notably, metabolic abnormalities observed with chronic exposure to HFD (likely during the late stages of disease development) may potentially occur independently of PGC-1α regulation within the muscle of rodents. Summarized evidence suggests the causal relationship between PGC-1α regulation and effective modulations of mitochondrial biogenesis and metabolic flexibility during the different stages of disease development. It further indicates that prominent interventions like caloric restriction and physical exercise may affect PGC-1α regulation during effective modulation of metabolic processes.
- 4 December 2023
- Published by Springer Nature in Pflügers Archiv - European Journal of Physiology
- Vol. 476 (3) , 283-293
Open AccessPotential regulatory role of PGC-1α within the skeletal muscle during metabolic adaptations in response to high-fat diet feeding in animal models
High-fat diet (HFD) feeding in rodents has become an essential tool to critically analyze and study the pathological effects of obesity, including mitochondrial dysfunction and insulin resistance. Peroxisome proliferator–activated receptor γ coactivator-1α (PGC-1α) regulates cellular energy metabolism to influence insulin sensitivity, beyond its active role in stimulating mitochondrial biogenesis to facilitate skeletal muscle adaptations in response to HFD feeding. Here, some of the major electronic databases like PubMed, Embase, and Web of Science were accessed to update and critically discuss information on the potential role of PGC-1α during metabolic adaptations within the skeletal muscle in response to HFD feeding in rodents. In fact, available evidence suggests that partial exposure to HFD feeding (potentially during the early stages of disease development) is associated with impaired metabolic adaptations within the skeletal muscle, including mitochondrial dysfunction and reduced insulin sensitivity. In terms of implicated molecular mechanisms, these negative effects are partially associated with reduced activity of PGC-1α, together with the phosphorylation of protein kinase B and altered expression of genes involving nuclear respiratory factor 1 and mitochondrial transcription factor A within the skeletal muscle. Notably, metabolic abnormalities observed with chronic exposure to HFD (likely during the late stages of disease development) may potentially occur independently of PGC-1α regulation within the muscle of rodents. Summarized evidence suggests the causal relationship between PGC-1α regulation and effective modulations of mitochondrial biogenesis and metabolic flexibility during the different stages of disease development. It further indicates that prominent interventions like caloric restriction and physical exercise may affect PGC-1α regulation during effective modulation of metabolic processes.
- Open Access
- 12 September 2023
- Published by Elsevier in Pharmacological Research
- Vol. 196, 106918
Sulforaphane: A nutraceutical against diabetes-related complications
- 12 September 2023
- Published by Elsevier in Pharmacological Research
- Vol. 196, 106918
Open AccessSulforaphane: A nutraceutical against diabetes-related complications
- Open Access
- 3 August 2023
- Published by Elsevier in South African Journal of Botany
- Vol. 160, 697-704
Rutin attenuates tumor necrosis factor-α-induced inflammation and initiates fat browning in 3T3-L1 adipocytes: Potential therapeutic implications for anti-obesity therapy
- 3 August 2023
- Published by Elsevier in South African Journal of Botany
- Vol. 160, 697-704
Open AccessRutin attenuates tumor necrosis factor-α-induced inflammation and initiates fat browning in 3T3-L1 adipocytes: Potential therapeutic implications for anti-obesity therapy
- Open Access
- 16 February 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1114767
An insight into brown/beige adipose tissue whitening, a metabolic complication of obesity with the multifactorial origin
Brown adipose tissue (BAT), a thermoregulatory organ known to promote energy expenditure, has been extensively studied as a potential avenue to combat obesity. Although BAT is the opposite of white adipose tissue (WAT) which is responsible for energy storage, BAT shares thermogenic capacity with beige adipose tissue that emerges from WAT depots. This is unsurprising as both BAT and beige adipose tissue display a huge difference from WAT in terms of their secretory profile and physiological role. In obesity, the content of BAT and beige adipose tissue declines as these tissues acquire the WAT characteristics via the process called “whitening”. This process has been rarely explored for its implication in obesity, whether it contributes to or exacerbates obesity. Emerging research has demonstrated that BAT/beige adipose tissue whitening is a sophisticated metabolic complication of obesity that is linked to multiple factors. The current review provides clarification on the influence of various factors such as diet, age, genetics, thermoneutrality, and chemical exposure on BAT/beige adipose tissue whitening. Moreover, the defects and mechanisms that underpin the whitening are described. Notably, the BAT/beige adipose tissue whitening can be marked by the accumulation of large unilocular lipid droplets, mitochondrial degeneration, and collapsed thermogenic capacity, by the virtue of mitochondrial dysfunction, devascularization, autophagy, and inflammation.
- 16 February 2023
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 14, 1114767
Open AccessAn insight into brown/beige adipose tissue whitening, a metabolic complication of obesity with the multifactorial origin
Brown adipose tissue (BAT), a thermoregulatory organ known to promote energy expenditure, has been extensively studied as a potential avenue to combat obesity. Although BAT is the opposite of white adipose tissue (WAT) which is responsible for energy storage, BAT shares thermogenic capacity with beige adipose tissue that emerges from WAT depots. This is unsurprising as both BAT and beige adipose tissue display a huge difference from WAT in terms of their secretory profile and physiological role. In obesity, the content of BAT and beige adipose tissue declines as these tissues acquire the WAT characteristics via the process called “whitening”. This process has been rarely explored for its implication in obesity, whether it contributes to or exacerbates obesity. Emerging research has demonstrated that BAT/beige adipose tissue whitening is a sophisticated metabolic complication of obesity that is linked to multiple factors. The current review provides clarification on the influence of various factors such as diet, age, genetics, thermoneutrality, and chemical exposure on BAT/beige adipose tissue whitening. Moreover, the defects and mechanisms that underpin the whitening are described. Notably, the BAT/beige adipose tissue whitening can be marked by the accumulation of large unilocular lipid droplets, mitochondrial degeneration, and collapsed thermogenic capacity, by the virtue of mitochondrial dysfunction, devascularization, autophagy, and inflammation.